Related Experiment Video
Updated: May 30, 2026
15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Autoimmunity in amyotrophic lateral sclerosis: past and present
Mario Rafael Pagani1, Laura Elisabeth Gonzalez, Osvaldo Daniel Uchitel
1Systems Neuroscience Section, Department of Physiology and Biophysics, School of Medicine, University of Buenos Aires, C1121ABG Buenos Aires, Argentina.
Neurology Research International
|August 10, 2011
Summary
Autoimmunity may play a role in Amyotrophic Lateral Sclerosis (ALS), a motor neuron disease. Research suggests immune responses targeting motor neurons could lead to cell death, offering potential diagnostic and therapeutic avenues.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease impacting motor neurons.
- Current treatments for ALS are limited, and its cause remains largely unknown.
- Emerging evidence suggests a potential autoimmune mechanism in ALS pathogenesis.
Purpose of the Study:
- To summarize research on autoimmunity in sporadic ALS.
- To discuss potential pathogenic mechanisms.
- To explore future perspectives for diagnosis and therapy.
Main Methods:
- Review of current scientific literature on autoimmunity and ALS.
- Analysis of data supporting immune responses against motor nerve terminals.
- Discussion of calcium homeostasis and apoptotic pathways.
Main Results:
- Humoral immune responses targeting motor nerve terminals may initiate pathological changes.
- Alterations in calcium homeostasis are implicated in neuronal dysfunction.
- Loss of calcium homeostasis can trigger neuronal death via apoptosis.
Conclusions:
- Autoimmunity is a plausible contributing factor in sporadic ALS.
- Understanding these autoimmune mechanisms could lead to early diagnostic tools.
- Targeting these pathways may offer novel therapeutic strategies for ALS.
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...